Inflammation in neurological disorders: a help or a hindrance?
about
Myelin damage and repair in pathologic CNS: challenges and prospectsExpanding the clinical indications for α(1)-antitrypsin therapyP2X4 receptors (P2X4Rs) represent a novel target for the development of drugs to prevent and/or treat alcohol use disordersThrombospondins as key regulators of synaptogenesis in the central nervous systemCritical Evaluation of P2X7 Receptor Antagonists in Selected Seizure ModelsThe transcriptional landscape of dorsal root ganglia after sciatic nerve transectionNano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative DiseasesIntegrated expression profiles of mRNA and miRNA in polarized primary murine microglia.Urinary Levels of IL-1β and GDNF in Preterm Neonates as Potential Biomarkers of Motor Development: A Prospective Study.Anti-neuroinflammatory effects of the calcium channel blocker nicardipine on microglial cells: implications for neuroprotection.Features of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity.Therapeutic window for cyclooxygenase-2 related anti-inflammatory therapy after status epilepticusRole of cerebrospinal fluid and plasma biomarkers in the diagnosis of neurodegenerative disorders and mild cognitive impairment.Reduced inflammation accompanies diminished myelin damage and repair in the NG2 null mouse spinal cord.The role of cytokines and inflammatory cells in perinatal brain injury.Cyclosporine immunomodulation retards regeneration of surgically transected corneal nerves.Blood circulating microparticle species in relapsing-remitting and secondary progressive multiple sclerosis. A case-control, cross sectional study with conventional MRI and advanced iron content imaging outcomes.Spatial and temporal correlation in progressive degeneration of neurons and astrocytes in contusion-induced spinal cord injuryMolecular mechanisms of ursodeoxycholic acid toxicity & side effects: ursodeoxycholic acid freezes regeneration & induces hibernation mode.Molecular Mechanisms Regulating LPS-Induced Inflammation in the Brain.Mechanisms of action of naturally occurring antibodies against β-amyloid on microglia.Role of neuroinflammation in adult neurogenesis and Alzheimer disease: therapeutic approachesReduction of microglial activity in a model of multiple sclerosis by dipyridamole.Functional roles of p38 mitogen-activated protein kinase in macrophage-mediated inflammatory responses.Modulation of dendritic cell function by PGE2 and DHA: a framework for understanding the role of dendritic cells in neuroinflammation.Inflammation in neurological and psychiatric diseases.The benefits of exercise training in multiple sclerosis.Non-coding RNAs in Alzheimer's disease.Neurosteroids and epileptogenesis.The benefits and detriments of macrophages/microglia in models of multiple sclerosisThe changing landscape of voltage-gated calcium channels in neurovascular disorders and in neurodegenerative diseasesInterrelation of oxidative stress and inflammation in neurodegenerative disease: role of TNF.Withstanding the obstructive sleep apnea syndrome at the expense of arousal instability, altered cerebral autoregulation and neurocognitive decline.Modulating the Immune Response Towards a Neuroregenerative Peri-injury Milieu After Cerebral Hemorrhage.Effect of Amaranthus on Advanced Glycation End-Products Induced Cytotoxicity and Proinflammatory Cytokine Gene Expression in SH-SY5Y Cells.Astrocytes Underlie Neuroinflammatory Memory Impairment.Myeloid cells - targets of medication in multiple sclerosis.Regulatory effects of fisetin on microglial activation.Ginsenoside Re Attenuates Neuroinflammation in a Symptomatic ALS Animal Model.Determinants of disability in multiple sclerosis: an immunological and MRI study.
P2860
Q26797407-9F92D28F-0823-4227-B260-145407FC44CBQ27000764-DB2AF593-D6C1-4F7C-A64D-A91D8B0E932BQ27021285-9F930634-F0BD-4FB6-B2A9-BC169C139508Q27024828-B25356A4-7280-4731-A85F-D2830CBB2B73Q27342573-3CB13C95-4900-4A9B-B1E6-6ED2C2DA48E4Q28394099-8C69689D-E3E6-46D4-85BA-0771A5FD1AE1Q28546214-F178A658-B40F-4E28-8B6C-BE18CD58A904Q31144077-5AC29E2C-7806-4814-82C0-CE5AA70F0AB2Q33695610-72431CCE-5E8C-47AB-B778-21231AFEE166Q35118654-9C00EEB4-B78B-417A-946A-A20C49B4759CQ35162073-3011837C-AF98-4F14-B6B4-CE953961656CQ35534894-786B61C1-7461-4525-AA74-E16D5EF4694DQ35542811-C0628A34-9799-4725-A811-F21497EB3E9DQ35588967-755F1407-0541-4AFA-A02D-F58105B7C4DBQ35864361-388B5A75-6359-487C-AE73-8836AA5C8868Q35865430-2204E10F-5D8D-4026-9CD4-2F3E959DED74Q35998171-4D3D48EB-06F5-4C17-BF61-BF78BC7A02FEQ36162573-564A922D-9BE0-4E09-B9A6-16ED7B1AAABCQ36197335-A977C849-51D4-4C35-9397-DD0B02867E0CQ36661061-EF53CFA4-724A-42C6-80FF-62C964E967DDQ36689356-F2990D17-3130-4D2D-BDEB-0CFC934DCA97Q36830938-50EAE572-7665-4552-B0F5-E06114BBEE85Q37048242-B31F0F35-995B-44BA-BBD6-2B74E1681759Q37688086-758D2ACE-F330-4BB1-94EA-FEAF0B0780DFQ37909028-B929E3D1-2EC3-410B-A2E5-B390D0C4E533Q37987805-71C496B1-87F0-4DDA-B85A-FF895D2E6935Q38028858-BFBB3DB5-7DB1-4087-BEB0-2D54B9D0C039Q38051212-4BE29DCA-2125-48A8-9C44-2B897B6EB941Q38114139-7DEBE21B-AB9A-43BD-BC2D-EBA917A87C07Q38120527-71E01455-D6B9-463A-B2A9-1ABBF16A51B2Q38157892-D36BFD66-0A24-40FE-803D-784E64169360Q38401306-76946454-65A3-4284-8DAB-5222966D1570Q38444331-80DF3947-C998-42B7-9975-E7E805ADC449Q38462525-AC449BA2-1F0D-444E-B74F-85AAC9BF7425Q38833562-3A4862DC-E68F-41AE-A4BB-6C09AAAED92CQ38906477-DE363F68-7E52-442C-9101-B06ED9A0112BQ38924828-AF4740A0-21C1-4352-AD90-8E3279CE1EBFQ38980358-A1D671AB-AE14-4A25-86A2-A053D484281BQ39849252-852C46E1-16F7-4442-A685-E7DA3FFEA6A0Q41129964-F1353BA4-4CCE-4C2C-9890-EFB19CE3C230
P2860
Inflammation in neurological disorders: a help or a hindrance?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inflammation in neurological disorders: a help or a hindrance?
@en
Inflammation in neurological disorders: a help or a hindrance?
@nl
type
label
Inflammation in neurological disorders: a help or a hindrance?
@en
Inflammation in neurological disorders: a help or a hindrance?
@nl
prefLabel
Inflammation in neurological disorders: a help or a hindrance?
@en
Inflammation in neurological disorders: a help or a hindrance?
@nl
P2860
P356
P1433
P1476
Inflammation in neurological disorders: a help or a hindrance?
@en
P2093
V Wee Yong
P2860
P304
P356
10.1177/1073858410371379
P577
2010-08-01T00:00:00Z